Report Detail
Global Alzheimer's Blood Tests Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4710890 |
- 17 June, 2026 |
- Global |
- 116 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Alzheimer's Blood Tests market size was valued at US$ 74.24 million in 2025 and is forecast to a readjusted size of US$ 131 million by 2032 with a CAGR of 8.4% during review period.
Alzheimer's blood tests refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500–900 per test.
The upstream supply chain of Alzheimer's blood tests mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, Aβ, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer's disease biomarker research.
The Alzheimer's blood tests market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, Aβ, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer’s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report is a detailed and comprehensive analysis for global Alzheimer's Blood Tests market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Alzheimer's Blood Tests market size and forecasts, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alzheimer's Blood Tests
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alzheimer's Blood Tests market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Fujirebio, Sysmex, Shimadzu, Diadem, Quanterix, ALZpath, Beckman Coulter Diagnostics, Siemens Healthineers, Vazyme, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Alzheimer's Blood Tests market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Biomarker Tests
Multi-Biomarker Panel Tests
Others
Market segment Testing Technology
Chemiluminescent Immunoassay
Single-Molecule and Ultra-Sensitive Immunoassay
Mass Spectrometry-Based Testing
Others
Market segment Commercialization Status
Commercialized Products
Products under Development or Registration
Research Use Only Products
Market segment by Application
Clinical Use
Non-Clinical Use
Market segment by players, this report covers
Roche
Fujirebio
Sysmex
Shimadzu
Diadem
Quanterix
ALZpath
Beckman Coulter Diagnostics
Siemens Healthineers
Vazyme
Hoyotek
BGI Genomics
Kemei Diagnostics
Maya Lightyear
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Alzheimer's Blood Tests product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Alzheimer's Blood Tests, with revenue, gross margin, and global market share of Alzheimer's Blood Tests from 2021 to 2026.
Chapter 3, the Alzheimer's Blood Tests competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Alzheimer's Blood Tests market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Alzheimer's Blood Tests.
Chapter 13, to describe Alzheimer's Blood Tests research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Alzheimer's Blood Tests by Type
- 1.3.1 Overview: Global Alzheimer's Blood Tests Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Alzheimer's Blood Tests Consumption Value Market Share by Type in 2025
- 1.3.3 Single Biomarker Tests
- 1.3.4 Multi-Biomarker Panel Tests
- 1.3.5 Others
- 1.4 Classification of Alzheimer's Blood Tests Testing Technology
- 1.4.1 Overview: Global Alzheimer's Blood Tests Market Size Testing Technology: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Alzheimer's Blood Tests Consumption Value Market Share Testing Technology in 2025
- 1.4.3 Chemiluminescent Immunoassay
- 1.4.4 Single-Molecule and Ultra-Sensitive Immunoassay
- 1.4.5 Mass Spectrometry-Based Testing
- 1.4.6 Others
- 1.5 Classification of Alzheimer's Blood Tests Commercialization Status
- 1.5.1 Overview: Global Alzheimer's Blood Tests Market Size Commercialization Status: 2021 Versus 2025 Versus 2032
- 1.5.2 Global Alzheimer's Blood Tests Consumption Value Market Share Commercialization Status in 2025
- 1.5.3 Commercialized Products
- 1.5.4 Products under Development or Registration
- 1.5.5 Research Use Only Products
- 1.6 Global Alzheimer's Blood Tests Market by Application
- 1.6.1 Overview: Global Alzheimer's Blood Tests Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Clinical Use
- 1.6.3 Non-Clinical Use
- 1.7 Global Alzheimer's Blood Tests Market Size & Forecast
- 1.8 Global Alzheimer's Blood Tests Market Size and Forecast by Region
- 1.8.1 Global Alzheimer's Blood Tests Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global Alzheimer's Blood Tests Market Size by Region, (2021-2032)
- 1.8.3 North America Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
- 1.8.4 Europe Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
- 1.8.6 South America Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Alzheimer's Blood Tests Product and Solutions
- 2.1.4 Roche Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Roche Recent Developments and Future Plans
- 2.2 Fujirebio
- 2.2.1 Fujirebio Details
- 2.2.2 Fujirebio Major Business
- 2.2.3 Fujirebio Alzheimer's Blood Tests Product and Solutions
- 2.2.4 Fujirebio Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Fujirebio Recent Developments and Future Plans
- 2.3 Sysmex
- 2.3.1 Sysmex Details
- 2.3.2 Sysmex Major Business
- 2.3.3 Sysmex Alzheimer's Blood Tests Product and Solutions
- 2.3.4 Sysmex Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Sysmex Recent Developments and Future Plans
- 2.4 Shimadzu
- 2.4.1 Shimadzu Details
- 2.4.2 Shimadzu Major Business
- 2.4.3 Shimadzu Alzheimer's Blood Tests Product and Solutions
- 2.4.4 Shimadzu Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Shimadzu Recent Developments and Future Plans
- 2.5 Diadem
- 2.5.1 Diadem Details
- 2.5.2 Diadem Major Business
- 2.5.3 Diadem Alzheimer's Blood Tests Product and Solutions
- 2.5.4 Diadem Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Diadem Recent Developments and Future Plans
- 2.6 Quanterix
- 2.6.1 Quanterix Details
- 2.6.2 Quanterix Major Business
- 2.6.3 Quanterix Alzheimer's Blood Tests Product and Solutions
- 2.6.4 Quanterix Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Quanterix Recent Developments and Future Plans
- 2.7 ALZpath
- 2.7.1 ALZpath Details
- 2.7.2 ALZpath Major Business
- 2.7.3 ALZpath Alzheimer's Blood Tests Product and Solutions
- 2.7.4 ALZpath Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 ALZpath Recent Developments and Future Plans
- 2.8 Beckman Coulter Diagnostics
- 2.8.1 Beckman Coulter Diagnostics Details
- 2.8.2 Beckman Coulter Diagnostics Major Business
- 2.8.3 Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Solutions
- 2.8.4 Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Beckman Coulter Diagnostics Recent Developments and Future Plans
- 2.9 Siemens Healthineers
- 2.9.1 Siemens Healthineers Details
- 2.9.2 Siemens Healthineers Major Business
- 2.9.3 Siemens Healthineers Alzheimer's Blood Tests Product and Solutions
- 2.9.4 Siemens Healthineers Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Siemens Healthineers Recent Developments and Future Plans
- 2.10 Vazyme
- 2.10.1 Vazyme Details
- 2.10.2 Vazyme Major Business
- 2.10.3 Vazyme Alzheimer's Blood Tests Product and Solutions
- 2.10.4 Vazyme Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Vazyme Recent Developments and Future Plans
- 2.11 Hoyotek
- 2.11.1 Hoyotek Details
- 2.11.2 Hoyotek Major Business
- 2.11.3 Hoyotek Alzheimer's Blood Tests Product and Solutions
- 2.11.4 Hoyotek Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Hoyotek Recent Developments and Future Plans
- 2.12 BGI Genomics
- 2.12.1 BGI Genomics Details
- 2.12.2 BGI Genomics Major Business
- 2.12.3 BGI Genomics Alzheimer's Blood Tests Product and Solutions
- 2.12.4 BGI Genomics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 BGI Genomics Recent Developments and Future Plans
- 2.13 Kemei Diagnostics
- 2.13.1 Kemei Diagnostics Details
- 2.13.2 Kemei Diagnostics Major Business
- 2.13.3 Kemei Diagnostics Alzheimer's Blood Tests Product and Solutions
- 2.13.4 Kemei Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Kemei Diagnostics Recent Developments and Future Plans
- 2.14 Maya Lightyear
- 2.14.1 Maya Lightyear Details
- 2.14.2 Maya Lightyear Major Business
- 2.14.3 Maya Lightyear Alzheimer's Blood Tests Product and Solutions
- 2.14.4 Maya Lightyear Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Maya Lightyear Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Alzheimer's Blood Tests Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Alzheimer's Blood Tests by Company Revenue
- 3.2.2 Top 3 Alzheimer's Blood Tests Players Market Share in 2025
- 3.2.3 Top 6 Alzheimer's Blood Tests Players Market Share in 2025
- 3.3 Alzheimer's Blood Tests Market: Overall Company Footprint Analysis
- 3.3.1 Alzheimer's Blood Tests Market: Region Footprint
- 3.3.2 Alzheimer's Blood Tests Market: Company Product Type Footprint
- 3.3.3 Alzheimer's Blood Tests Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Alzheimer's Blood Tests Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Alzheimer's Blood Tests Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Alzheimer's Blood Tests Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
- 6.2 North America Alzheimer's Blood Tests Market Size by Application (2021-2032)
- 6.3 North America Alzheimer's Blood Tests Market Size by Country
- 6.3.1 North America Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
- 6.3.2 United States Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 6.3.3 Canada Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
- 7.2 Europe Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
- 7.3 Europe Alzheimer's Blood Tests Market Size by Country
- 7.3.1 Europe Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
- 7.3.2 Germany Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 7.3.3 France Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 7.3.5 Russia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 7.3.6 Italy Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Alzheimer's Blood Tests Market Size by Region
- 8.3.1 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Region (2021-2032)
- 8.3.2 China Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 8.3.3 Japan Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 8.3.5 India Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 8.3.7 Australia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
- 9.2 South America Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
- 9.3 South America Alzheimer's Blood Tests Market Size by Country
- 9.3.1 South America Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Alzheimer's Blood Tests Market Size by Country
- 10.3.1 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
- 10.3.4 UAE Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Alzheimer's Blood Tests Market Drivers
- 11.2 Alzheimer's Blood Tests Market Restraints
- 11.3 Alzheimer's Blood Tests Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Alzheimer's Blood Tests Industry Chain
- 12.2 Alzheimer's Blood Tests Upstream Analysis
- 12.3 Alzheimer's Blood Tests Midstream Analysis
- 12.4 Alzheimer's Blood Tests Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Alzheimer's Blood Tests. Industry analysis & Market Report on Alzheimer's Blood Tests is a syndicated market report, published as Global Alzheimer's Blood Tests Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Alzheimer's Blood Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
